SpectraCure AB (2OK) Stock Statistics & Valuation Metrics

SpectraCure AB has a market cap or net worth of €3.31M. The enterprise value is €4.85M.

SpectraCure AB has 570,602,840 shares outstanding. The number of shares has decreased by -2.65% in one year.

SpectraCure AB’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -56.40%.

The current PE Ratio of SpectraCure AB is ―. SpectraCure AB’s PEG ratio is 0.03.

In the last 12 months, SpectraCure AB had revenue of 0.00 and earned -56.08M in profits. Earnings per share was -0.14.

In the last 12 months, operating cash flow was -23.75M and capital expenditures -15.71M, giving a free cash flow of -28.61M billion.

SpectraCure AB pays an annual dividend of ―, resulting in a dividend yield of ―

SpectraCure AB upcoming earnings date is Aug 21, 2026, Before Open (Confirmed).

SpectraCure AB as a current ratio of 1.52, with Debt / Equity ratio of 2.18%

In the past 12 months, SpectraCure AB has paid 27.00K in taxes.

SpectraCure AB EV to EBITDA ratio is -2.20, with an EV/FCF ratio of -1.22.

SpectraCure AB has €16.59M in cash and marketable securities with €2.19M in debt, giving a net cash position of €14.41M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for SpectraCure AB is ―, which is 11.43% higher than the current price. The consensus rating is ―